Monday, June 4, 2007

 

UAE Approves Rimonabant (Acomplia/Zimulti)

The United Arab Emirates (UAE) became the first country to launch Acomplia/Zimulti in the Middle East.

A recent survey found that 37 percent of the UAE population is now obese -- one of the highest obesity rates in the Middle East, according to Sanofi.

"Among people who are overweight or obese, it is those with excess fat around their abdomen who are at the greatest risk of developing an abnormal lipid profile, type 2 diabetes and ultimately heart disease," said Dr. Wael Al Mahmeed, Vice President of the Emirates Cardiac Society.

Labels: , ,


Comments: Post a Comment

Subscribe to Post Comments [Atom]



Links to this post:

Create a Link



<< Home

This page is powered by Blogger. Isn't yours?

Subscribe to Posts [Atom]